{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:36:55Z","timestamp":1784907415168,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD036071"],"award-info":[{"award-number":["HD036071"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH078041"],"award-info":[{"award-number":["MH078041"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010553","name":"MIND Institute, University of California, Davis","doi-asserted-by":"publisher","award":["U54 HD079125"],"award-info":[{"award-number":["U54 HD079125"]}],"id":[{"id":"10.13039\/100010553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00695","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T04:27:54Z","timestamp":1534912074000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia"],"prefix":"10.3389","volume":"9","author":[{"given":"Jessica L.","family":"Famula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingratana A.","family":"McLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Martinez-Cerdeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/13854046.2016.1202239","article-title":"Fragile X-associated tremor\/ataxia syndrome: phenotypic comparisons with other movement disorders","volume":"30","author":"Robertson","year":"2016","journal-title":"Clin Neuropsychol."},{"key":"B6","first-page":"1757","article-title":"Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction","volume":"23","author":"Brunberg","year":"2002","journal-title":"AJNR Am J Neuroradiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/386296","article-title":"The fragile-X premutation: a maturing perspective","volume":"74","author":"Hagerman","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-33898-9_4","article-title":"Neuroimaging Findings in FXTAS","volume-title":"FXTAS, FXPOI, and Other Premutation Disorders","author":"Halket","year":"2016"},{"key":"B10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12311-016-0799-4","article-title":"Update on the clinical, radiographic, and neurobehavioral manifestations in FXTAS and FMR1 premutation carriers","volume":"15","author":"Hall","year":"2016","journal-title":"Cerebellum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/bj20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biochem J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.celrep.2013.02.004","article-title":"Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor\/ataxia syndrome","volume":"3","author":"Sellier","year":"2013","journal-title":"Cell Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"B15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12311-016-0779-8","article-title":"Altered bioenergetics in primary dermal fibroblasts from adult carriers of the FMR1 premutation before the onset of the neurodegenerative disease fragile X-associated tremor\/ataxia syndrome","volume":"15","author":"Napoli","year":"2016","journal-title":"Cerebellum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/hmg\/ddx148","article-title":"Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of Fragile X-associated tremor-ataxia syndrome","volume":"26","author":"Robin","year":"2017","journal-title":"Hum Mol Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","article-title":"Translation of expanded CGG repeats into FMRpolyG Is pathogenic and may contribute to fragile X tremor ataxia syndrome","volume":"93","author":"Sellier","year":"2017","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12311-016-0776-y","article-title":"A majority of FXTAS cases present with intranuclear inclusions within purkinje cells","volume":"15","author":"Ariza","year":"2016","journal-title":"Cerebellum"},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/jmg.2007.054171","article-title":"A low symptomatic form of neurodegeneration in younger carriers of the FMR1 premutation, manifesting typical radiological changes","volume":"45","author":"Loesch","year":"2008","journal-title":"J Med Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome","volume":"56","author":"Filipovic-Sadic","year":"2010","journal-title":"Clin Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations","volume":"10","author":"Tassone","year":"2008","journal-title":"J Mol Diagn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/157340013805289635","article-title":"Cognitive dysfunction in FMR1 premutation carriers","volume":"9","author":"Seritan","year":"2013","journal-title":"Curr Psychiatry Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.03.018","article-title":"Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s1474-4422(13)70125-x","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/mds.26902","article-title":"Iron accumulation and dysregulation in the putamen in fragile X-associated tremor\/ataxia syndrome","volume":"32","author":"Ariza","year":"2017","journal-title":"Mov Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/mds.27060","article-title":"Two FMR1 premutation cases without nuclear inclusions","volume":"32","author":"Martinez-Cerdeno","year":"2017","journal-title":"Mov Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12311-016-0798-5","article-title":"Cerebellar mild iron accumulation in a subset of FMR1 premutation carriers with FXTAS","volume":"15","author":"Rogers","year":"2016","journal-title":"Cerebellum"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/ajh\/hpu032","article-title":"Progression of brain microbleeds in essential hypertensive patients: a 2-year follow-up study","volume":"27","author":"van","year":"2014","journal-title":"Am J Hypertens"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/ajmg.a.35323","article-title":"Hypertension in FMR1 premutation males with and without fragile X-associated tremor\/ataxia syndrome (FXTAS)","author":"Hamlin","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/awf077","article-title":"Hypertension and cerebral white matter lesions in a prospective cohort study","volume":"125","author":"de","year":"2002","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archneur.64.2.289-a","article-title":"Fragile X syndrome vs fragile X-associated tremor\/ataxia syndrome","volume":"64","author":"Leehey","year":"2007","journal-title":"Arch Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mds.27314","article-title":"Age- and CGG repeat-related slowing of manual movement in fragile X carriers: a prodrome of FXTAS?","volume":"33","author":"Shickman","year":"2018","journal-title":"Movement Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ajmg.b.30482","article-title":"CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor\/ataxia syndrome (FXTAS)","author":"Tassone","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1000119","DOI":"10.4172\/2168-975x.1000119","article-title":"Molecular advances leading to treatment implications for fragile X premutation carriers","volume":"3","author":"Polussa","year":"2014","journal-title":"Brain Disord Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/ajmg.a.37030","article-title":"Methadone use in a male with the FMRI premutation and FXTAS","volume":"167","author":"Muzar","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1042\/bcj20160585","article-title":"Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation","volume":"473","author":"Giulivi","year":"2016","journal-title":"Biochem J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s13311-017-0555-6","article-title":"Open-label allopregnanolone treatment of men with fragile X-associated tremor\/ataxia syndrome","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T04:27:56Z","timestamp":1534912076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":39,"alternative-id":["10.3389\/fneur.2018.00695"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00695","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"article-number":"695"}}